Dumevska Biljana, Bosman Alexis, McKernan Robert, Schmidt Uli, Peura Teija
Genea Biocells, Sydney, Australia.
Stem Cell Res. 2016 Mar;16(2):472-5. doi: 10.1016/j.scr.2016.02.011. Epub 2016 Feb 11.
The Genea022 human embryonic stem cell line was derived from a donated, fully commercially consented ART blastocyst, through ICM outgrowth on inactivated feeders. The line showed pluripotent cell morphology and genomic analysis verified a 46, XY karyotype and male allele pattern through CGH and STR analysis. Pluripotency of Genea022 was demonstrated with 84% of cells expressed Nanog, 98% Oct4, 55% Tra1-60 and 97% SSEA4, gave a Pluritest Pluripotency score of 42.95, Novelty of 1.23, demonstrated Alkaline Phosphatase activity and tri-lineage teratoma formation. The cell line was negative for Mycoplasma and visible contamination.
Genea022人胚胎干细胞系源自一个捐赠的、已获得完全商业同意的辅助生殖技术囊胚,通过在灭活饲养层上进行内细胞团生长培养获得。该细胞系呈现多能干细胞形态,基因组分析通过比较基因组杂交(CGH)和短串联重复序列(STR)分析,证实其核型为46, XY且具有男性等位基因模式。Genea022的多能性表现为84%的细胞表达Nanog,98%表达Oct4,55%表达Tra1-60,97%表达阶段特异性胚胎抗原4(SSEA4),Pluritest多能性评分为42.95,新颖性评分为1.23,具有碱性磷酸酶活性并能形成三胚层畸胎瘤。该细胞系支原体检测为阴性且无可见污染。